- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by AstraZeneca
Total 4281 results
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease | COPDUnited States, France, Poland, South Africa, Canada, Germany
-
AstraZenecaCompleted
-
AstraZenecaCompletedAsthmaHungary, South Africa, Poland, Spain, Canada, Australia, Czech Republic
-
AstraZenecaCompletedRhinitis, Allergic, PerennialUnited States
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD)United Kingdom
-
AstraZenecaCompleted
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease | Chronic Bronchitis
-
AstraZenecaCompleted
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease, COPDFrance, Poland, South Africa, Spain, United States, Canada, United Kingdom
-
AstraZenecaCompletedAsthmaUnited States, Argentina, Colombia, Mexico, Peru
-
AstraZenecaCompletedNon-Small Cell Lung Cancer | Advanced Solid Malignancies | Neoplasms, | Metastatic Cancer,Japan
-
AstraZenecaCompletedSolid TumoursBelgium, Denmark, United Kingdom, Netherlands
-
AstraZenecaCompletedNon-Small-Cell Lung CancerTaiwan
-
AstraZenecaCompletedHypertriglyceridemiaUnited States
-
AstraZenecaCompletedAdvanced Breast CancerUnited States, Australia, Brazil
-
AstraZenecaCompleted
-
AstraZenecaCompletedHealthy VolunteerUnited States
-
AstraZenecaCompletedType 2 DiabetesUnited States, Puerto Rico, Mexico, Russian Federation, Romania, Poland, Czech Republic, United Kingdom
-
AstraZenecaCompleted
-
AstraZenecaTerminatedPreviously Treated Non Small Cell Lung CancerUnited States
-
AstraZenecaTerminatedNon-ST Elevation Acute Coronary SyndromeUnited States
-
AstraZenecaCompleted
-
AstraZenecaWithdrawn
-
AstraZenecaCompletedDyslipidaemiaRussian Federation
-
AstraZenecaCompletedType 2 Diabetes Mellitus
-
AstraZenecaCompletedAdvanced Solid Tumor | Advanced Solid MalignancyJapan
-
AstraZenecaCompletedMelanomaSweden, United States, Brazil, Czech Republic, France, Spain, United Kingdom, Germany, Norway, Hungary, Netherlands, Switzerland
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD)Austria, Bulgaria, Canada, Czech Republic, France, Germany, Hungary, Italy, Lithuania, Netherlands, Poland, South Africa, Spain, United Kingdom
-
AstraZenecaCompletedAsthmaBulgaria, Czech Republic, Mexico, Poland, Russian Federation, South Africa, United Kingdom, Germany, Romania, Ukraine, Canada, Hungary, Slovakia
-
AstraZenecaCompletedThe Tolerability and Effects of AZD8848 in Allergic Asthma Subjects Challenged With Inhaled AllergenAllergic AsthmaUnited Kingdom
-
AstraZenecaCompleted
-
AstraZenecaCompletedFGFR Inhibition, Pharmacokinetics, Biomarkers | ER+ Breast CancerCzech Republic, Italy, United Kingdom, Hungary, Germany, Romania, Belgium, France
-
AstraZenecaCompletedProstate CancerSweden, United States, Brazil, Czech Republic, France, Russian Federation, United Kingdom, Germany, China, Hungary, Poland, Finland, Netherlands, Mexico, Hong Kong, Australia, Belgium, Canada, Denmark, Portugal, South Africa, Korea... and more
-
AstraZenecaCompletedPharmacokinetic Profile | Plasma ConcentrationUnited Kingdom
-
AstraZenecaCompletedNeoplasms | Breast Cancer | Breast NeoplasmsBrazil, Bulgaria, Czech Republic, Peru, Spain, United Kingdom, Sweden, Hungary, Belgium, Canada, Italy, France, Panama, Switzerland
-
AstraZenecaCompletedBreast CancerCroatia, Sweden, Czech Republic, France, Italy, Peru, Turkey, United Kingdom, Romania, Finland, Australia, Austria, Belgium, Switzerland, Greece, Colombia, Chile, Venezuela
-
AstraZenecaCompletedLINE: Treatment Patterns in postmenopausaL Women With Hormone Receptor Positive Breast Cancer (LINE)Local Advanced or Metastatic Postmenopausal Breast CancerRussian Federation
-
AstraZenecaCompletedAcute Coronary SyndromeUnited States
-
AstraZenecaCompleted
-
AstraZenecaCompleted
-
AstraZenecaCompletedAdvanced Solid Malignancies | Malignant LymphomaUnited Kingdom, Japan
-
AstraZenecaCompletedHealthy VolunteersUnited Kingdom
-
AstraZenecaCompletedBreast NeoplasmsUnited States, Australia, Brazil, South Africa, Spain, United Kingdom, Argentina, Belgium, Canada, France, Germany, Denmark
-
AstraZenecaCompletedHealthy Japanese Children Age 2 Years Through 6 YearsJapan
-
AstraZenecaCompletedDiabetes Mellitus, Type 1United States
-
AstraZenecaCompletedRefractory Reflux EsophagitisJapan
-
AstraZenecaCompleted
-
AstraZenecaCompletedHealthy Subjects | Safety, | Tolerability,United Kingdom